Health Care & Life Sciences » Pharmaceuticals | Assembly Biosciences Inc.

Assembly Biosciences Inc. | Ownership

Companies that own Assembly Biosciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Ecor1 Capital LLC
2,943,164
11.57%
-1
12.23%
06/30/2018
Jennison Associates LLC
2,471,615
9.71%
36,369
0.09%
06/30/2018
Acuta Capital Partners LLC
1,162,000
4.57%
47,000
8.11%
06/30/2018
BlackRock Fund Advisors
1,074,055
4.22%
128,822
0%
06/30/2018
venBio Select Advisor LLC
963,427
3.79%
-130,507
1.32%
06/30/2018
Henderson Global Investors Ltd.
805,425
3.17%
243,582
0.01%
06/30/2018
The Vanguard Group, Inc.
777,625
3.06%
16,688
0%
06/30/2018
OrbiMed Advisors LLC
721,166
2.83%
0
0.3%
06/30/2018
Rock Springs Capital Management LP
450,000
1.77%
7,000
0.65%
06/30/2018
SSgA Funds Management, Inc.
363,685
1.43%
73,578
0%
06/30/2018

About Assembly Biosciences

View Profile
Address
11711 North Meridian Street
Carmel Indiana 46032
United States
Employees -
Website http://www.assemblybio.com
Updated 07/08/2019
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.